AustralieFrV1, Ncbi, Merge, bibRecord, 001983

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Identifieur interne : 001983 ( Ncbi/Merge ); précédent : 001982; suivant : 001984

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Auteurs : Valery L. Feigin [Nouvelle-Zélande] ; Priya G. Parmar ; Suzanne Barker-Collo ; Derrick A. Bennett ; Craig S. Anderson ; Amanda G. Thrift ; Birgitta Stegmayr ; Peter M. Rothwell ; Maurice Giroud ; Yannick Bejot ; Phillip Carvil ; Rita Krishnamurthi ; Nikola Kasabov

Source :

Stroke [ 1524-4628 ] ; 2014.

RBID : pubmed:24757102

Descripteurs français

KwdFr :
- Accident vasculaire cérébral (), Accident vasculaire cérébral (épidémiologie), Accident vasculaire cérébral (étiologie), Adolescent, Adulte, Adulte d'âge moyen, Australie (épidémiologie), Europe (épidémiologie), Facteurs de risque, Femelle, Humains, Mâle, Nouvelle-Zélande (épidémiologie), Phénomènes magnétiques, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
MESH :
- épidémiologie : Accident vasculaire cérébral, Australie, Europe, Nouvelle-Zélande.
- étiologie : Accident vasculaire cérébral.
- Accident vasculaire cérébral, Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Mâle, Phénomènes magnétiques, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
Wicri :
- geographic : Australie, Nouvelle-Zélande.

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Australia (epidemiology), Europe (epidemiology), Female, Humans, Magnetic Phenomena, Male, Middle Aged, New Zealand (epidemiology), Retrospective Studies, Risk Factors, Stroke (epidemiology), Stroke (etiology), Stroke (prevention & control).
MESH :
- geographic , epidemiology : Australia, Europe, New Zealand.
- epidemiology : Stroke.
- etiology : Stroke.
- prevention & control : Stroke.
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Magnetic Phenomena, Male, Middle Aged, Retrospective Studies, Risk Factors.

Abstract

Although the research linking cardiovascular disorders to geomagnetic activity is accumulating, robust evidence for the impact of geomagnetic activity on stroke occurrence is limited and controversial.

DOI: 10.1161/STROKEAHA.113.004577
PubMed: 24757102

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 003706
to stream PubMed, to step Curation: 003592
to stream PubMed, to step Checkpoint: 003592

Links to Exploration step

pubmed:24757102

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.</title>
<author><name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
<affiliation wicri:level="1"><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.). valery.feigin@aut.ac.nz.</nlm:affiliation>
<country wicri:rule="url">Nouvelle-Zélande</country>
</affiliation>
</author>
<author><name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24757102</idno>
<idno type="pmid">24757102</idno>
<idno type="doi">10.1161/STROKEAHA.113.004577</idno>
<idno type="wicri:Area/PubMed/Corpus">003706</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003706</idno>
<idno type="wicri:Area/PubMed/Curation">003592</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003592</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003592</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003592</idno>
<idno type="wicri:Area/Ncbi/Merge">001983</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.</title>
<author><name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
<affiliation wicri:level="1"><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.). valery.feigin@aut.ac.nz.</nlm:affiliation>
<country wicri:rule="url">Nouvelle-Zélande</country>
</affiliation>
</author>
<author><name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<affiliation><nlm:affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</nlm:affiliation>
<wicri:noCountry code="subField">United Kingdom (P.C.).</wicri:noCountry>
</affiliation>
</author>
</analytic>
<series><title level="j">Stroke</title>
<idno type="eISSN">1524-4628</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Australia (epidemiology)</term>
<term>Europe (epidemiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Phenomena</term>
<term>Male</term>
<term>Middle Aged</term>
<term>New Zealand (epidemiology)</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Stroke (epidemiology)</term>
<term>Stroke (etiology)</term>
<term>Stroke (prevention & control)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Accident vasculaire cérébral ()</term>
<term>Accident vasculaire cérébral (épidémiologie)</term>
<term>Accident vasculaire cérébral (étiologie)</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Australie (épidémiologie)</term>
<term>Europe (épidémiologie)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Nouvelle-Zélande (épidémiologie)</term>
<term>Phénomènes magnétiques</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Australia</term>
<term>Europe</term>
<term>New Zealand</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Stroke</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Accident vasculaire cérébral</term>
<term>Australie</term>
<term>Europe</term>
<term>Nouvelle-Zélande</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Accident vasculaire cérébral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Magnetic Phenomena</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Accident vasculaire cérébral</term>
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Phénomènes magnétiques</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Australie</term>
<term>Nouvelle-Zélande</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although the research linking cardiovascular disorders to geomagnetic activity is accumulating, robust evidence for the impact of geomagnetic activity on stroke occurrence is limited and controversial.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24757102</PMID>
<DateCreated><Year>2014</Year>
<Month>07</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>08</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1524-4628</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>45</Volume>
<Issue>6</Issue>
<PubDate><Year>2014</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Stroke</Title>
<ISOAbbreviation>Stroke</ISOAbbreviation>
</Journal>
<ArticleTitle>Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.</ArticleTitle>
<Pagination><MedlinePgn>1639-45</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1161/STROKEAHA.113.004577</ELocationID>
<Abstract><AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Although the research linking cardiovascular disorders to geomagnetic activity is accumulating, robust evidence for the impact of geomagnetic activity on stroke occurrence is limited and controversial.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">We used a time-stratified case-crossover study design to analyze individual participant and daily geomagnetic activity (as measured by Ap Index) data from several large population-based stroke incidence studies (with information on 11 453 patients with stroke collected during 16 031 764 person-years of observation) in New Zealand, Australia, United Kingdom, France, and Sweden conducted between 1981 and 2004. Hazard ratios and corresponding 95% confidence intervals (CIs) were calculated.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, geomagnetic storms (Ap Index 60+) were associated with 19% increase in the risk of stroke occurrence (95% CI, 11%-27%). The triggering effect of geomagnetic storms was most evident across the combined group of all strokes in those aged <65 years, increasing stroke risk by >50%: moderate geomagnetic storms (60-99 Ap Index) were associated with a 27% (95% CI, 8%-48%) increased risk of stroke occurrence, strong geomagnetic storms (100-149 Ap Index) with a 52% (95% CI, 19%-92%) increased risk, and severe/extreme geomagnetic storms (Ap Index 150+) with a 52% (95% CI, 19%-94%) increased risk (test for trend, P<2×10(-16)).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Geomagnetic storms are associated with increased risk of stroke and should be considered along with other established risk factors. Our findings provide a framework to advance stroke prevention through future investigation of the contribution of geomagnetic factors to the risk of stroke occurrence and pathogenesis.</AbstractText>
<CopyrightInformation>© 2014 American Heart Association, Inc.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feigin</LastName>
<ForeName>Valery L</ForeName>
<Initials>VL</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.). valery.feigin@aut.ac.nz.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Parmar</LastName>
<ForeName>Priya G</ForeName>
<Initials>PG</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Barker-Collo</LastName>
<ForeName>Suzanne</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bennett</LastName>
<ForeName>Derrick A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Anderson</LastName>
<ForeName>Craig S</ForeName>
<Initials>CS</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Thrift</LastName>
<ForeName>Amanda G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Stegmayr</LastName>
<ForeName>Birgitta</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rothwell</LastName>
<ForeName>Peter M</ForeName>
<Initials>PM</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Giroud</LastName>
<ForeName>Maurice</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bejot</LastName>
<ForeName>Yannick</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Carvil</LastName>
<ForeName>Phillip</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krishnamurthi</LastName>
<ForeName>Rita</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kasabov</LastName>
<ForeName>Nikola</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>From the National Institute for Stroke and Applied Neurosciences (V.L.F., P.G.P., R.K.) and Knowledge Engineering and Discovery Research Institute (N.K.), Auckland University of Technology, Auckland, New Zealand; School of Psychology, The University of Auckland, Auckland, New Zealand (S.B.-C.); Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health (D.A.B.) and University Department of Clinical Neurology (P.M.R.), University of Oxford, Oxford, United Kingdom; Neurological and Mental Health Division at the George Institute for Global Health, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (C.S.A.); Department of Medicine, Southern Clinical School, Monash University Melbourne, Melbourne, Australia (A.G.T.); Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden (B.S.); Service de Neurologie, Centre Hospitalo-Universitaire, Dijon, France (M.G.); University Hospital and Faculty of Medicine of Dijon, EA 4183, University of Burgundy, Stroke Registry of Dijon (Inserm and Invs), Dijon, France (Y.B.); and Centre of Human Aerospace and Physiological Science, King's College London, London, United Kingdom (P.C.).</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>International Stroke Incidence Studies Data Pooling Project Collaborators</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>095626</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>04</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Stroke</MedlineTA>
<NlmUniqueID>0235266</NlmUniqueID>
<ISSNLinking>0039-2499</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060328" MajorTopicYN="Y">Magnetic Phenomena</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009520" MajorTopicYN="N" Type="Geographic">New Zealand</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">environment</Keyword>
<Keyword MajorTopicYN="N">stroke</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>4</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>8</Month>
<Day>19</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24757102</ArticleId>
<ArticleId IdType="pii">STROKEAHA.113.004577</ArticleId>
<ArticleId IdType="doi">10.1161/STROKEAHA.113.004577</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Nouvelle-Zélande</li>
</country>
</list>
<tree><noCountry><name sortKey="Anderson, Craig S" sort="Anderson, Craig S" uniqKey="Anderson C" first="Craig S" last="Anderson">Craig S. Anderson</name>
<name sortKey="Barker Collo, Suzanne" sort="Barker Collo, Suzanne" uniqKey="Barker Collo S" first="Suzanne" last="Barker-Collo">Suzanne Barker-Collo</name>
<name sortKey="Bejot, Yannick" sort="Bejot, Yannick" uniqKey="Bejot Y" first="Yannick" last="Bejot">Yannick Bejot</name>
<name sortKey="Bennett, Derrick A" sort="Bennett, Derrick A" uniqKey="Bennett D" first="Derrick A" last="Bennett">Derrick A. Bennett</name>
<name sortKey="Carvil, Phillip" sort="Carvil, Phillip" uniqKey="Carvil P" first="Phillip" last="Carvil">Phillip Carvil</name>
<name sortKey="Giroud, Maurice" sort="Giroud, Maurice" uniqKey="Giroud M" first="Maurice" last="Giroud">Maurice Giroud</name>
<name sortKey="Kasabov, Nikola" sort="Kasabov, Nikola" uniqKey="Kasabov N" first="Nikola" last="Kasabov">Nikola Kasabov</name>
<name sortKey="Krishnamurthi, Rita" sort="Krishnamurthi, Rita" uniqKey="Krishnamurthi R" first="Rita" last="Krishnamurthi">Rita Krishnamurthi</name>
<name sortKey="Parmar, Priya G" sort="Parmar, Priya G" uniqKey="Parmar P" first="Priya G" last="Parmar">Priya G. Parmar</name>
<name sortKey="Rothwell, Peter M" sort="Rothwell, Peter M" uniqKey="Rothwell P" first="Peter M" last="Rothwell">Peter M. Rothwell</name>
<name sortKey="Stegmayr, Birgitta" sort="Stegmayr, Birgitta" uniqKey="Stegmayr B" first="Birgitta" last="Stegmayr">Birgitta Stegmayr</name>
<name sortKey="Thrift, Amanda G" sort="Thrift, Amanda G" uniqKey="Thrift A" first="Amanda G" last="Thrift">Amanda G. Thrift</name>
</noCountry>
<country name="Nouvelle-Zélande"><noRegion><name sortKey="Feigin, Valery L" sort="Feigin, Valery L" uniqKey="Feigin V" first="Valery L" last="Feigin">Valery L. Feigin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001983 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001983 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:24757102
   |texte=   Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:24757102" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Geomagnetic storms can trigger stroke: evidence from 6 large population-based studies in Europe and Australasia.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki